Description: Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan. It offers its products in various therapeutic areas, including cardiovascular, respiratory, urology, sex hormone, and oncology. The company provides its products in various forms, such as effervescent tablets, granules, nasal sprays, metered dosed inhalers, hormones, and other forms. It also offers contract manufacturing services. In addition, it exports its products to South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua. The company was incorporated in 1980 and is based in Taipei, Taiwan.
Home Page: www.synmosa.com.tw
No. 396, Neihu Road
Taipei,
114
Taiwan
Phone:
886 2 8797 7100
Officers
| Name | Title |
|---|---|
| Mr. Chih-Hui Lin | Chairman, GM, Mang.ial Officer & Pres |
| Mr. Hong-Qin Bai | Sr. VP & Fin. Officer |
| Mr. Hung-Chin Pai | Sr. VP & Accounting Officer |
| Mr. Zen Young | VP of Sales - HP, Marketing & Medical |
| Ms. Jia-Xin Zhang | Sr. VP |
| Mr. Sheng-Ren Yang | Sr. VP |
| Mr. Banson Lin | Sr. Assistant to Chief Exec. Officer - Distributors |
Exchange: TWO
Country: TW
Currency: New Taiwan Dollar (NT$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 18.7821 |
| Price-to-Book MRQ: | 3.0888 |
| Price-to-Sales TTM: | 4.0565 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |